Journals / Retina-Vitreus / 2005 / Cilt: 13 - Sayı: 2

Anterior hyaloidal fibrovascular proliferation after vitrectomy in cases with proliferative diabetic retinopathy

Proliferatif diyabetik retinaopatili olgularda vitrektomi sonrası ön hyaloidal fibrovasküler proliferasyon

Pages
107–113
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Tight regulation of diabetes and especially the prevention of anemia is necessary along with intensive surgical treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To determine the frequency of anterior hyaloidal fibrovascular proliferation(AHFVP) after pars plana vitrectomy (PPV) in patients with proliferative diabetic retinopathy; to evaluate the properties of these patients and the anatomical, functional results of surgical treatments.
📊
Key Findings & Data:Materials and Methods: The records of patients in which PPV was performed due to tractional retinal detachment, intravitreal hemorrhage between January 2001-April 2004 were retrospectively reviewed.
💡
Conclusion & Impact:Tight regulation of diabetes and especially the prevention of anemia is necessary along with intensive surgical treatment
🔬Design:Review & Systematic Survey
📍Scope:2001 Verileri
⚙️Variables:Diabetik retinopati · Ameliyat sonrası komplikasyonlar · Retina dekolmanı

Abstract

Purpose: To determine the frequency of anterior hyaloidal fibrovascular proliferation(AHFVP) after pars plana vitrectomy (PPV) in patients with proliferative diabetic retinopathy; to evaluate the properties of these patients and the anatomical, functional results of surgical treatments. Materials and Methods: The records of patients in which PPV was performed due to tractional retinal detachment, intravitreal hemorrhage between January 2001-April 2004 were retrospectively reviewed. The demographic properties, the type, the duration of diabetes, postoperative AHFVP development time and the anatomical, functional results of surgical treatments were evaluated. Results: Out of 201 eyes, AHFVP developed after a mean of 2.3 (1-5) months postoperatively in 9 eyes (4.4%) of 7 patients (male/female:4/3) in which 5 out of 7 were type I DM with a mean age of 38,2 (24-69). 4 patients had diabetic nephropathy, anemia. Median BCVA was hand motion (light perception- 2m counting fingers). Only equatorial cryotherapy (EK) was performed in 1 patient; in 8 eyes PPV with intensive endolaser (n:8), lens extraction (n:5), scleral buckling (n:1), EK (n:6) were performed. At the end of a mean follow-up time of 7.1 (1-12) months, retina was attached in 5 and detached in 4 eyes. Phtysis developed in 1 eye. Postoperative median BCVA was light perception; 2 eyes lost light perception. Conclusion: With surgical treatment, anatomical success was achieved in 55% of eyes with AHFVP; however, visual aquities remained at low levels. Postoperative close followup of patients who carry high risks of developing AHFVP is very important for the early diagnosis and treatment. Tight regulation of diabetes and especially the prevention of anemia is necessary along with intensive surgical treatment

Özet

Amaç: Proliferatif diyabetik retinopati (PDR) nedeniyle pars plana vitrektomi (PPV) uygulanan olgularda postoperatif dönemde ön hyaloidal fibrovasküler proliferasyon (ÖHFVP) gelişim sıklığını ve bu olguların özelliklerini belirlemek; cerrahi tedavilerin anatomik ve fonksiyonel sonuçlarını incelemek. Gereç ve Yöntem: Ocak 2001-Nisan 2004 tarihleri arasında traksiyonel retina dekolmanı, vitreus hemorajisi nedeniyle PPV uygulanan olguların kayıtları retrospektif olarak değerlendirildi. ÖHFVP gelişen olgularda demografik özellikler, diyabet tipi ve süresi, postoperatif ÖHFVP gelişim zamanı ve ÖHFVP'nin cerrahi tedavisinin anatomik, fonksiyonel sonuçları incelendi. Bulgular: 201 gözden, ortalama yaşı 38,2 (24-69), 5'i tip I DM'li 7 hastanın (erkek/kadın:4/3) 9 gözünde (%4.4) postoperatif ortalama 2.3 (1-5) ay sonra ÖHFVP gelişti. Dördünde diyabetik nefropati, anemi mevcuttu. Olguların medyan en iyi görme keskinliği (EİGK) el hareketi (ışık hissi- 2 mps) seviyesindeydi. 1 olguya sadece ekvatoryal kriyoterapi (EK); 8 göze ise PPV'yle birlikte yoğun endolaser (n:8), lens ekstraksiyonu (n:5), skleral çökertme (n:1), EK (n:6) uygulandı. Postoperatif ortalama 7.1 (1-12) ay takip sonunda retina 5 gözde yatışık, 4 gözde dekoleydi. 1 gözde fitizis gelişti. Postoperatif medyan EİGK ışık hissiydi; 2 gözde ışık hissi kaybedildi. Sonuç: Cerrahi tedaviyle ÖHFVP'li gözlerin % 55'inde anatomik başarı sağlanmıştır, ancak görme seviyesi düşük seviyede kalmıştır. ÖHFVP gelişimi açısından yüksek risk taşıyan olguların postoperatif yakın takibi, bu ciddi komplikasyonun erken tanısı, tedavisi için çok önemlidir. Yoğun cerrahi tedavinin yanı sıra, diyabetin sıkı regülasyonu ve özellikle aneminin önlenmesi gereklidir.

🔖

Cite This Article

ACAR, N., KAPRAN, Z., ÜNVER, Y. B., ÖZTÜRKER, Z. K., BAYRAKTAR, Z., ÇAKIR, M. (2005). Anterior hyaloidal fibrovascular proliferation after vitrectomy in cases with proliferative diabetic retinopathy. Retina-Vitreus, Cilt: 13 - Sayı: 2, 107–113. https://ajindex.com/articles/305332

References (15)

  1. Aiello LP, Gardner TW, King GL, et al.: Diabetic retinopathy. Diabetes Care. 1998;21:143-156
  2. American Diebetes Association: Diabetic retinopathy (position statement). Diabetes Care 1998; 21:547-549
  3. Patz A, Smith RE: The ETDRS and Diabetes 2000. Ophthalmology 1991;98:739-740
  4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329: 977-986
  5. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent daibetes mellitus. Arch Ophthalmol 1995,113:36-51
  6. The Diabetic Retinopathy Study Research Group: Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81:383-396
  7. The Diabetic Retinopathy Study Research Group: Photo-coagulation treatment of proliferative diabetic retinopathy: the second report of the Diabetic Retinopathy Study findings. Ophthalmology 1978;85:82-106
  8. The Diabetic Retinopathy Study Research Group. Photo-coagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 198;88:583-600
  9. Doft BH, Metz DJ, Kelsey SF: Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation. Ophthalmology 1992; 99: 1728-1734; discussion 1734-1735
  10. Vine AK: The efficacy of additional argon laser photocoagulation for persistent, severe proliferative diabetic retinopathy. Ophthalmology 1985;92:1532-1537
  11. Flynn HW Jr, Chew EY, Simons BD, et al: Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS Report Number 17. Ophthalmology. 1992;99:1351 -1357
  12. Blankenship GW, Machemer R: Long-term diabetic vitrectomy results: report of a 10 year follow-up. Ophthalmology. 1985; 92: 503-506
  13. Hasanreisoğlu B, Bilgihan K, Akbatur H ve ark. Proliferatif Diyabetik Retinopati Olgusunda Vitrektomi: Komplikasyonlar ve Sonuçlar. Ret-Vit 1993;1:44-48
  14. Williams DF, Williams GA, Hartz, A et al: Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique. Ophthalmology 1989;96:752-758
  15. Lewis H, Abrams GW, Williams GA.: Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 1987 Dec 1